pH-responsive drug release

pH-responsive drug release is a sophisticated pharmacological strategy rather than a biological molecule or receptor. It exploits the natural pH variations found throughout the body, such as the acidic environment of the stomach (pH 1-3), the neutrality of the blood (pH 7.4), and the localized acidity of tumors (pH 6.5-6.8) and intracellular compartments like endosomes (pH 5.0-6.0) or lysosomes (pH 4.5-5.0). By utilizing materials that undergo structural or chemical changes at specific pH thresholds, researchers can design 'smart' nanocarriers that protect their cargo during transit and release it only at the desired site of action. This approach is particularly prominent in oncology, where the Warburg effect leads to increased lactic acid production and extracellular acidity, providing a trigger for localized chemotherapy release. Consequently, pH-responsive systems enhance the therapeutic index of drugs by maximizing efficacy at the target site while minimizing systemic side effects.

Other names

pH-triggered drug deliverypH-sensitive drug releaseAcidity-responsive drug delivery systemspH-sensitive nanocarriers

The mechanism involves the release of a therapeutic payload triggered by physiological or pathological pH gradients. This is achieved via pH-dependent protonation, solubility changes, or the cleavage of acid-labile chemical bonds (e.g., hydrazone, acetal, or orthoester linkages) within a drug carrier, allowing for localized delivery in acidic environments like tumor microenvironments or endosomes.